Deutsche Bank analyst George Hill maintains HealthEquity (NASDAQ:HQY) with a Buy and raises the p

HealthEquity posted significant sales and earnings beats with its fiscal Q2 report. The company issu

Canada Pension Plan Investment Board purchased a new stake in HealthEquity, Inc. (NASDAQ: HQY) durin

HealthEquity (NASDAQ: HQY) reported accelerated revenue growth and record profitability in its fisca

HealthEquity, Inc. (HQY) Q2 2027 Earnings Call Transcript

Gainers Celularity (NASDAQ:CELU) stock moved upwards by 134.0% to $2.06 during Thursday's regul

U.S. stocks traded higher, Dow up 0.20%, NASDAQ up 1.05%, S&P 500 up 0.47%. Tech shares jumped 2

HealthEquity NASDAQ: HQY reported accelerated revenue growth and record profitability in its fiscal

While the top- and bottom-line numbers for HealthEquity (HQY) give a sense of how the business perfo

HealthEquity (HQY) came out with quarterly earnings of $1.24 per share, beating the Zacks Consensus

HealthEquity (NASDAQ:HQY) reported second-quarter financial results on Thursday. The transcript from

HealthEquity (NASDAQ:HQY) reported quarterly earnings of $1.24 per share which beat the analyst cons

HealthEquity (NASDAQ:HQY) affirms FY2027 Adj EPS guidance from $4.66-$4.73 to $4.66-$4.73 vs $4.72 a

HealthEquity (NASDAQ:HQY) raises FY2027 GAAP EPS guidance from $2.88-$2.95 to $2.88-$2.96 vs $2.94 a

Highlights of the second quarter include: Net income increased 10% to $65.6 million, and net income

Bamco Inc. NY bought a new position in HealthEquity, Inc. (NASDAQ: HQY) during the second quarter, a

Beyond analysts' top-and-bottom-line estimates for HealthEquity (HQY), evaluate projections for some

Handelsbanken Fonder AB boosted its position in shares of HealthEquity, Inc. (NASDAQ: HQY) by 20.2%

Amundi increased its holdings in HealthEquity, Inc. (NASDAQ: HQY) by 2,130.8% during the undefined q

DRAPER, Utah, Aug. 03, 2026 (GLOBE NEWSWIRE) -- HealthEquity, Inc. (NASDAQ: HQY) (“HealthEquity” or

HealthEquity (HQY) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the

Castleark Management LLC bought a new position in shares of HealthEquity, Inc. (NASDAQ: HQY) during

HealthEquity is the leading HSA and CDB administrator, consistently beating revenue and EPS expectat

Bank of New York Mellon Corp trimmed its position in HealthEquity, Inc. (NASDAQ: HQY) by 3.6% during

BTIG analyst David Larsen maintains HealthEquity (NASDAQ:HQY) with a Buy and raises the price tar

The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investi

Allspring Global Investments Holdings LLC trimmed its position in shares of HealthEquity, Inc. (NASD

HQY benefits from strong HSA growth, AI-driven automation and solid first-quarter fiscal 2027 result

RBC Capital analyst Ryan Halsted reiterates HealthEquity (NASDAQ:HQY) with a Outperform and maint

Citizens analyst Constantine Davides maintains HealthEquity (NASDAQ:HQY) with a Market Outperform

RBC Capital analyst Ryan Halsted maintains HealthEquity (NASDAQ:HQY) with a Outperform and raises

Top Wall Street analysts changed outlook on top names. See analyst ratings for upgrades, downgrades

Top analysts change outlook on top names, like AA, SSSS, TXN, HQY, LUCD, RPM, PAR, ASRT. Morgan Stan

Top Wall Street analysts changed their outlook on top names. See analyst ratings page for upgrades,

BMO Capital analyst Sean Dodge upgrades HealthEquity (NASDAQ:HQY) from Market Perform to Outperfo

Deutsche Bank analyst George Hill maintains HealthEquity (NASDAQ:HQY) with a Buy and raises the p

HealthEquity Inc (NASDAQ: HQY) beat earnings expectations for Q4, with adjusted EPS of 95 cents. FY2

Barrington Research analyst Alexander Paris maintains HealthEquity (NASDAQ:HQY) with a Outperform

JP Morgan analyst Alexei Gogolev maintains HealthEquity (NASDAQ:HQY) with a Overweight and lowers

RBC Capital analyst Daniel R. Perlin maintains HealthEquity (NASDAQ:HQY) with a Outperform and lo

HealthEquity, Inc. (NASDAQ: HQY) to release Q4 earnings on 3/17. Analysts expect earnings of $0.90/s

Barclays analyst Glen Santangelo maintains HealthEquity (NASDAQ:HQY) with a Overweight and lowers

HealthEquity (NASDAQ:HQY) affirms FY2026 Adj EPS guidance from $3.87-$3.95 to $3.87-$3.95 vs $3.95 a

HealthEquity (NASDAQ:HQY) affirms FY2027 sales outlook from $1.380 billion-$1.410 billion to $1.380

BTIG analyst David Larsen maintains HealthEquity (NASDAQ:HQY) with a Buy and lowers the price tar

HealthEquity, Inc. (NASDAQ: HQY) ("HealthEquity" or the "Company"), the nation's